Novo Seeds, the early-stage investment and company creation team of Novo Holdings, has invested in a new portfolio company Hemab ApS, which is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders. 14 December 2020
French immunotherapy specialist Transgene said yesterday that its board had approved the appointment of Hedi Ben Brahim as its new chairman and chief executive, effective January 1, 2021. 4 December 2020
UK-based rare diseases specialist Mereo BioPharma today announced the appointment of Dr Suba Krishnan as senior vice president of clinical development, effective December 7, 2020. 23 November 2020
The new head of the European Medicines Agency, Emer Cooke, has formally started work in the role, kicking off a five-year renewable mandate as executive director. 16 November 2020
Boehringer Ingelheim said today it has recently welcomed Yew Looi Liew (YL) as the newly-appointed president of US Human Pharma at its US headquarters, Boehringer Ingelheim Pharmaceuticals based in Ridgefield, CT, which is the German family-owned drug major’s largest US subsidiary. 30 October 2020
EXUMA Biotech Corporation, the company discovering and developing CAR-T products and delivery solutions for liquid and solid tumors, has announced an update to its senior leadership team. 19 October 2020
Germany’s Merck KGaA today announced that Dr Luciano Rossetti will be retiring as global head of R&D for the Healthcare business sector. 15 October 2020
AffaMed Therapeutics today announced a definitive merger agreement with fellow Shanghai, China-based biopharmaceutical company EverInsight Therapeutics. 14 October 2020
UK-based medicines manufacturer and supplier Morningside Pharmaceuticals has appointed a new chief executive, with previous CEO Nik Kotecha to take on a strategic role and become chairman of the board. 7 October 2020
US pharma giant Merck & Co on Friday announced that Roger Perlmutter will be retiring as executive vice president and president, Merck Research Laboratories (MRL). 5 October 2020
Dr Daniel Vasella, former chairman and chief executive of Swiss pharma giant Novartis, has been appointed the new and independent chairman of the board of Swiss biotech Numab Therapeutics. 30 September 2020
David Nicholson, the former executive vice president and chief R&D officer at Allergan, has been named chairman of the board of directors at UK-based Exscientia. 29 September 2020
Germany’s Merck KGaA today announced that next year Dr Stefan Oschmann, chairman of the firm’s executive board of Merck, will hand over the position to Dr Belén Garijo, who will also become chief executive on May 1, 2021. 28 September 2020
French drugmaker Ipsen today announced the appointment of Philippe Lopes-Fernandes as executive vice president, chief business officer, effective October 1, 2020. 25 September 2020
California, USA-based Nutcracker Therapeutics, a company developing and producing mRNA therapeutics, today announced not only a financing deal but also a new senior executive. 23 September 2020
Privately-held Danish medical dermatology specialist LEO Pharma today said that Becki Morison will join the company, effective October 1 in the position of executive vice president, global therapeutics and value strategy. 23 September 2020
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Biosimilar-focused biopharmaceutical company and contract development and manufacturing organization (CDMO) Tanvex BioPharma has named Stephen Lam its new chief executive (CEO). 5 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024